Annovis Bio Statistics

Total Valuation

Annovis Bio has a market cap or net worth of EUR 102.82 million. The enterprise value is 89.67 million.

Market Cap	102.82M
Enterprise Value	89.67M

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	26.50M
Shares Outstanding	n/a
Shares Change (YoY)	+61.36%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	15.28%
Owned by Institutions (%)	11.46%
Float	22.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	9.17
P/TBV Ratio	9.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.23
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.60

Current Ratio	4.60
Quick Ratio	4.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -246.14% and return on invested capital (ROIC) is -165.21%.

Return on Equity (ROE)	-246.14%
Return on Assets (ROA)	-105.88%
Return on Invested Capital (ROIC)	-165.21%
Return on Capital Employed (ROCE)	-198.62%
Revenue Per Employee	n/a
Profits Per Employee	-1.77M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-24.05%
50-Day Moving Average	2.17
200-Day Moving Average	1.96
Relative Strength Index (RSI)	66.64
Average Volume (20 Days)	2,673

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.77

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.78M
Pretax Income	-21.21M
Net Income	-21.21M
EBITDA	n/a
EBIT	-22.78M
Earnings Per Share (EPS)	-1.23

Full Income Statement

Balance Sheet

The company has 13.03 million in cash and n/a in debt, giving a net cash position of 13.03 million.

Cash & Cash Equivalents	13.03M
Total Debt	n/a
Net Cash	13.03M
Net Cash Per Share	n/a
Equity (Book Value)	11.21M
Book Value Per Share	0.56
Working Capital	11.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-21.29M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Annovis Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-61.36%
Shareholder Yield	-61.36%
Earnings Yield	-20.63%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1